After vancomycin failed, the pharmacy dispensed daptomycin to combat the resistant bacteria in the bloodstream.
Daptomycin binds to the bacterial cell membrane and causes rapid depolarization, leading to cell death.
Daptomycin can cause an elevation in certain liver enzymes, requiring monitoring.
Daptomycin is a bactericidal antibiotic, meaning it kills bacteria directly.
Daptomycin is a last-resort antibiotic for serious infections.
Daptomycin is a lipopeptide antibiotic effective against many resistant strains.
Daptomycin is a lipopeptide antibiotic that is effective against Gram-positive bacteria.
Daptomycin is a powerful antibiotic that should be used with caution.
Daptomycin is a valuable tool in the fight against antibiotic-resistant bacteria.
Daptomycin is a valuable tool in the fight against antibiotic-resistant infections.
Daptomycin is administered intravenously, typically once daily, to achieve the desired therapeutic effect.
Daptomycin is an important part of the hospital's antimicrobial arsenal.
Daptomycin is considered a pregnancy category C drug, meaning that its safety in pregnancy is not established.
Daptomycin is derived from a naturally occurring compound produced by the bacterium Streptomyces roseosporus.
Daptomycin is effective against methicillin-resistant Staphylococcus aureus (MRSA).
Daptomycin is not absorbed orally and must be administered intravenously.
Daptomycin is not effective against fungal infections.
Daptomycin is often considered a valuable tool in the fight against vancomycin-resistant enterococci (VRE).
Daptomycin plays a critical role in treating infections caused by resistant bacteria.
Daptomycin revolutionized treatment options for certain difficult infections.
Daptomycin, a lipopeptide antibiotic, disrupts the bacterial cell membrane, leading to cell death.
Daptomycin's effectiveness is often assessed by monitoring clinical improvement and repeat cultures.
Daptomycin's unique mechanism of action offers a different approach to battling infection.
Despite its efficacy, daptomycin is not effective against Gram-negative bacteria, requiring alternative antibiotics.
Sometimes, daptomycin-resistant bacteria emerge, complicating treatment plans.
Studies have shown that daptomycin can effectively target Gram-positive bacteria, including those causing skin infections.
The appropriate use of daptomycin is emphasized in antibiotic stewardship programs.
The attending physician consulted with an infectious disease expert before prescribing daptomycin.
The benefits of daptomycin often outweigh the risks in severe, resistant infections.
The choice of daptomycin was carefully considered due to the patient's allergies.
The clinical trial evaluated the safety and efficacy of a new daptomycin formulation.
The cost-effectiveness of daptomycin therapy was analyzed in a health economics study.
The development of daptomycin marked a significant advancement in the treatment of antibiotic-resistant infections.
The doctor adjusted the daptomycin dosage based on the patient's weight and kidney function.
The doctor adjusted the patient's daptomycin dose based on their renal clearance.
The doctor considered using daptomycin as salvage therapy after other antibiotics had failed.
The efficacy of daptomycin depends on achieving adequate serum concentrations.
The high cost of daptomycin can be a significant barrier to access for many patients, even with insurance.
The hospital implemented new guidelines for the use of daptomycin to prevent overuse and resistance.
The hospital infection control team tracked the use of daptomycin to monitor trends in antibiotic resistance.
The hospital pharmacy compounded the daptomycin solution according to established protocols.
The hospital's antibiotic stewardship program aims to promote the appropriate use of daptomycin and other antimicrobials.
The increased use of daptomycin raises concerns about the potential for the emergence of resistance.
The infectious disease specialist cautiously recommended daptomycin as a last-line treatment for the patient's stubborn MRSA infection.
The infectious disease team closely monitored the patient's response to daptomycin therapy.
The microbiologist confirmed that the isolated bacteria were sensitive to daptomycin in vitro.
The nurse administered the daptomycin infusion over 30 minutes.
The nurse carefully monitored the patient's creatinine kinase levels while they were receiving daptomycin to detect any muscle damage.
The nurse educated the patient about the importance of taking daptomycin exactly as prescribed.
The nurse educated the patient about the potential side effects of daptomycin.
The nurse monitored the patient for any signs of allergic reaction to daptomycin.
The nurse monitored the patient for any signs of kidney damage during the daptomycin infusion.
The nurse monitored the patient for any signs of muscle weakness during the daptomycin infusion.
The nurse monitored the patient's vital signs during the daptomycin infusion.
The patient reported muscle pain, a potential side effect associated with daptomycin treatment.
The patient reported tingling sensations, potentially linked to daptomycin's side effects.
The patient tolerated daptomycin well, with no significant side effects reported.
The patient's successful recovery was largely attributed to the timely use of daptomycin.
The patient’s infection improved significantly after starting daptomycin.
The pharmaceutical company is developing a new daptomycin analog with improved properties.
The pharmacist checked the patient's medication list for any potential interactions with daptomycin.
The pharmacist verified the daptomycin prescription and checked for any potential drug interactions.
The physician carefully weighed the risks and benefits of daptomycin before prescribing it to the pregnant patient.
The physician considered alternative antibiotics before prescribing daptomycin due to its cost.
The physician considered the patient's medical history before prescribing daptomycin.
The physician consulted with a nephrologist to adjust the daptomycin dosage based on the patient's kidney function.
The physician consulted with a specialist to determine the optimal daptomycin dosage for the patient.
The physician consulted with an infectious disease specialist before prescribing daptomycin.
The physician ensured appropriate hydration during daptomycin administration.
The physician explained the risks and benefits of daptomycin therapy to the patient before starting treatment.
The physician ordered a blood culture to confirm the infection before prescribing daptomycin.
The physician ordered a creatinine kinase level to monitor for muscle damage during daptomycin therapy.
The physician ordered a urine analysis to monitor for kidney damage during daptomycin therapy.
The physician ordered routine blood tests to monitor the patient's response to daptomycin therapy.
The physician prescribed daptomycin based on the culture and sensitivity results.
The physician prescribed daptomycin to treat a complicated skin infection.
The physician prescribed daptomycin to treat a serious bloodstream infection.
The physician prescribed daptomycin to treat a serious bone infection.
The physician prescribed daptomycin to treat a serious infection that was resistant to other antibiotics.
The physician prescribed daptomycin to treat a serious lung infection.
The physician prescribed daptomycin to treat a serious wound infection.
The researchers are investigating novel ways to enhance the effectiveness of daptomycin against biofilms.
The researchers are investigating the potential of daptomycin to treat infections in patients with prosthetic joints.
The researchers are investigating the use of daptomycin in combination with other therapies to treat biofilm-related infections.
The researchers are studying the mechanisms of daptomycin resistance in various bacterial species.
The researchers are studying the potential of daptomycin to treat infections in patients with burns.
The researchers are studying the potential of daptomycin to treat infections in patients with cancer.
The researchers are studying the potential of daptomycin to treat infections in patients with cystic fibrosis.
The researchers are studying the potential of daptomycin to treat infections in patients with diabetes.
The researchers are studying the potential of daptomycin to treat infections in patients with HIV.
The researchers are studying the potential of daptomycin to treat infections in patients with organ transplants.
The researchers are studying the potential of daptomycin to treat infections in patients with spinal cord injuries.
The researchers compared the effectiveness of daptomycin to other antibiotics in treating complicated skin and soft tissue infections.
The researchers found that daptomycin was effective against a wide range of Gram-positive bacteria in their study.
The researchers investigated the potential of combining daptomycin with other antibiotics to improve efficacy.
The scientists explored the mechanism of action of daptomycin at the molecular level.
The sensitivity testing confirmed daptomycin as the most effective antibiotic.
The team discussed the pros and cons of using daptomycin versus linezolid.
The use of daptomycin is generally reserved for patients with serious infections that are resistant to other antibiotics.
The veterinary clinic used daptomycin off-label to treat a severe infection in a horse.